AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip
Drug discovery remains a protracted and capital-intensive process, primarily hindered by inefficiencies in drug screening. Microfluidic technology provides a promising approach for <i>in vitro</i> drug screening, enabling physiologically relevant, high-throughput, and cost-effective analysis by mimicking …
Read PDF